Accéder au contenu
MilliporeSigma
Toutes les photos(2)

Documents

59353-U

Supelco

Discovery® C8 (5 µm) HPLC Columns

L × I.D. 15 cm × 4.6 mm, HPLC Column

Synonyme(s) :

C8 Reversed-Phase Chromatography Column

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Code UNSPSC :
41115700
eCl@ss :
32110501
Nomenclature NACRES :
SB.52

product name

Colonne HPLC Discovery® C8, 5 μm particle size, L × I.D. 15 cm × 4.6 mm

Matériaux

stainless steel column

Agence

suitable for USP L7

Gamme de produits

Discovery®

Caractéristiques

endcapped

Fabricant/nom de marque

Discovery®

Conditionnement

1 ea of

Ampleur du marquage

7.5% Carbon loading

Paramètres

≤70 °C temp. range
400 bar pressure (5801 psi)

Technique(s)

HPLC: suitable
LC/MS: suitable

L × D.I.

15 cm × 4.6 mm

Superficie

200 m2/g

Couverture de surface

3.4 μmol/m2

Impuretés

<10 ppm metals

Matrice

silica gel, high purity, spherical base material
fully porous particle

Groupe de la matrice active

C8 (octyl) phase

Taille des particules

5 μm

Dimension de pores

180 Å

operating pH range

2-8

Application(s)

food and beverages

Technique de séparation

reversed phase

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Application

Discovery® C8 HPLC column has been used in the separation of fluoroquinolone antibiotics in tablets using reversed-phase high-performance liquid chromatography (RP-HPLC).

Caractéristiques et avantages

Caractéristiques des Discovery® C8:
• Excellente reproductibilité
• Séparations plus rapide des analytes fortement hydrophobes que les colonnes C18
• Stable, pas de relargage pour séparations LC/MS
• Formes de pics exceptionnelles pour les composés acides et basiques
Compatible avec les phases mobiles aqueuses à teneur en organique faible ou élevée

Informations légales

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Choose from one of the most recent versions:

Certificats d'analyse (COA)

Lot/Batch Number
292563-06
292563-05
292563-04
292563-03
292563-02

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

M Q Zhang et al.
Die Pharmazie, 46(10), 687-700 (1991-10-01)
The rapid growth in the quinolone research changed the whole face of the previous SAR concepts. So far structural modifications at all positions of the quinolone nucleus except the 4-oxo group have successfully lead to the discovery of potent antimicrobial
G L Bundy et al.
The Journal of biological chemistry, 261(2), 747-751 (1986-01-15)
The gorgonian coral Pseudoplexaura porosa contains a lipoxygenase capable of converting exogenous arachidonic acid into (8R)-8-hydroperoxy-5,9,11,14-eicosatetraenoic acid. The (8R)- (or 8-L-) configuration in this product, opposite to that observed in previously reported 8-lipoxygenase products, was determined unambiguously by comparison of
Hugo M Botelho et al.
Scientific reports, 5, 9038-9038 (2015-03-13)
Plasma membrane proteins are essential molecules in the cell which mediate interactions with the exterior milieu, thus representing key drug targets for present pharma. Not surprisingly, protein traffic disorders include a large range of diseases sharing the common mechanism of
Simeon Grazio et al.
Clinical and experimental rheumatology, 31(5), 665-671 (2013-06-07)
Using proteomic approach in this study, we sought to identify proteins with heparin affinity associated with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and non-inflammatory arthritis (NIA). Plasma samples from adult RA, PsA and NIA patients, 20 of each, were collected.
Wai Shun Mak et al.
Nature communications, 6, 10005-10005 (2015-11-26)
The ability to biosynthetically produce chemicals beyond what is commonly found in Nature requires the discovery of novel enzyme function. Here we utilize two approaches to discover enzymes that enable specific production of longer-chain (C5-C8) alcohols from sugar. The first
Afficher tous les articles scientifiques apparentés

Protocoles

Separations of Tetracycline Antibiotics by Reversed Phase HPLC, Using Discovery Columns

Separations of Tetracycline Antibiotics by Reversed Phase HPLC, Using Discovery Columns

Contenu apparenté

Discovery C18 and C8 HPLC Columns

Discovery C18 and C8 HPLC Columns products offered

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique